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Objective: Capturing long-term outcomes from large clinical databases by use of claims data is a potential strategy for
improving efﬁciency while reducing study costs. We sought to compare the use of Medicare data with data from the
Women’s Health Initiative (WHI) to determine peripheral vascular events, as deﬁned by the WHI study design.
Methods: We studied participants from the WHI with both adjudicated outcomes and links to Medicare enrollment and
utilization data through 2007. Outcomes of interest included hospitalizations for treatment of abdominal aortic aneu-
rysm (AAA), lower extremity peripheral artery disease (LE PAD), and carotid artery stenosis (CAS). Events determined
by WHI adjudication were compared with events deﬁned by coding algorithms using diagnosis and procedure codes from
Medicare data with a pilot data set and then validated with a test data set. We assessed agreement by a k statistic and
evaluated reasons for disagreement.
Results: In the pilot set, records from 50,511 participants were analyzed. Agreement between the Centers for Medicare
and Medicaid Services and WHI for admissions with a diagnosis but no treatment procedures for vascular conditions
was poor (k, 0.02-0.18). On the basis of WHI outcome data collection, vascular treatment procedures occurred in 29
participants for AAA, 204 for LE PAD events, and 281 for CAS. Medicare hospital claims recorded 41 treatments for
AAA, 255 for LE PAD, and 317 for CAS. For participants with a Centers for Medicare and Medicaid Services-captured
vascular procedure and a record adjudicated by WHI, k values for treatment procedures were 0.81 for AAA, 0.77 for
PAD, and 0.93 for CAS. For vascular procedures identiﬁed by WHI but not by Medicare hospital data (n [ 82), 55%
were captured by Medicare physician claims. Conversely, for treatments identiﬁed by Medicare hospital data but not
captured by WHI adjudication (n [ 57), 74% had physician claims consistent with the procedure. Fifteen participants
with AAA or LE PAD procedures in hospital claims had medical records available for review, and nine of these had
deﬁnitive documentation of procedures that were not captured by the WHI adjudication process. Estimated positive
predictive value of Medicare data was 91% to 94% for AAA, 92% to 95% for LE PAD, and 94% to 99% for CAS.
Available test set data (n [ 50,253) yielded generally similar results with k of 0.77 for AAA, 0.79 for LE PAD, and
0.94 for CAS.
Conclusions: Medicare data appear useful for identifying vascular treatment procedures for WHI participants. Medicare
hospital claims identify more procedures than WHI does, with high positive predictive value, but also may not capture
some procedures identiﬁed in WHI. (J Vasc Surg 2014;60:98-105.)the Stanford University, Stanforda; the Fred Hutchinson Cancer
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://dx.doi.org/10.1016/j.jvs.2014.01.056Reliable detection of clinical outcomes is important for
randomized trials and prospective cohort studies, but it
can be expensive and difﬁcult to obtain. These studies would
be much simpler to perform if routinely collected clinical or
administrative data could be used in outcome analyses. One
strategy for studying clinical outcomes while reducing study
costs would be to capture long-term clinical outcomes
among study participants from already-existing electronic
health care databases. Medicare is one such database that
has electronic data on hospitalizations and outpatient en-
counters for Americans predominantly aged 65 years and
older. Medicare claims data are increasingly used for health
services research studies and observational studies and occa-
sionally as an adjunctive form of data collection for clinical
trials. Medicare has been used extensively to study a variety
of vascular conditions.1-6 The value of claims data to identify
peripheral arterial disease outcomes is uncertain. In this anal-
ysis, we sought to compare the use of Medicare data with
use of data from the Women’s Health Initiative (WHI) for
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well as treatment procedures as deﬁned by the WHI study
design in participants predominantly aged 65 years or older.
METHODS
Data sources. The WHI enrolled 161,808 women 50
to 79 years of age nationwide between 1993 and 1998 in a
set of randomized clinical trials and an observational study,
with ongoing longitudinal follow-up. Data from women
enrolled in WHI have been linked to Medicare enrollment
and utilization data from the Centers for Medicare and
Medicaid Services (CMS) by social security number, birth
or death date (or partial date), or zip code. For this analysis,
to include only women with fee-for-service Medicare
coverage whose claims would be routinely submitted to
CMS, we included WHI participants who were enrolled in
Medicare parts A and B (approximately 80% of the cohort)
and not in a Medicare Advantage managed care plan
(approximately 20% of the cohort). CMS ﬁles used for data
collection included the Medicare Provider and Analysis
Review (MedPAR) ﬁle, which has information for in-
patient hospitalizations; Carrier ﬁles containing informa-
tion on physician charges; and the Denominator and
Beneﬁciary Summary Files, which contain demographics,
enrollment in a Medicare health maintenance organization
(HMO), and information regarding coverage during the
study period. More information about the Medicare ﬁles
can be obtained from the Research Data Assistance Center
(http://www.resdac.org/cms-data).
Study population. WHI participants were included if
they met the Medicare criteria deﬁned before either at the
time of WHI enrollment or during WHI follow-up. We
divided this WHI-Medicare cohort into a pilot data set and
test data set. The test set included participants in both
hormone trials and observational study (with use of pre-
viously published methods7) in which subsequent periph-
eral vascular disease was an outcome of interest. Selection
of the test set was partially motivated by a planned analysis
of hormone therapy trial and observational study partici-
pants with use of previously published methods. The pilot
data set was therefore selected from the remaining WHI
participants for whom the entry criteria were similar but
who would not meet criteria for analysis.7 These included
WHI dietary modiﬁcation trial participants who were not
in the hormone therapy trials and a subset of observational
study participants (those with a history of breast cancer
reported at baseline, no mammogram within 2 years before
WHI enrollment, or use of hormone therapy but not the
same regimen as in the trial). We used Medicare data
through 2007. Follow-up was censored when a participant
no longer met the deﬁned Medicare criteria or after the last
WHI self-report or proxy report or death.
Outcomes ascertainment. In the WHI, participants
were requested to complete annual or semiannual question-
naires that included information about interimhospitalizations
and speciﬁc medical conditions. Once reported, medical re-
cords were obtained from hospitals and reviewed by physician
adjudicators to conﬁrm clinical events of interest based onstandardized case deﬁnitions.8 If a participant was unable to
complete the questionnaire, a proxy (eg, family member) was
requested to complete the form. Hospitalizations without
events of interest and hospitalizations with incomplete or un-
available documentation were not adjudicated.
Carotid artery disease, abdominal aortic aneurysm
(AAA), and lower extremity peripheral artery disease
(LE PAD) were counted as events only if they led to hos-
pitalization and were either symptomatic or required inter-
vention. WHI criteria for the end point of carotid artery
disease included occlusion or stenosis (CAS), with or
without cerebral infarction, and were based on hospitaliza-
tion with a vascular or surgical treatment procedure or hos-
pitalization with documented symptomatic disease and
either a discharge summary indicating carotid artery disease
or documented $50% stenosis on an imaging test (carotid
angiography, magnetic resonance angiography, or Doppler
ﬂow study). PAD was deﬁned in WHI as AAA, LE claudi-
cation, atherosclerosis, or arterial embolism or thrombosis.
AAA was based on hospitalization and either an imaging
test (ultrasound, angiography) or a treatment procedure
(surgical or vascular). LE PAD was based on hospitaliza-
tion with an imaging test demonstrating stenosis or
ulcerated plaque ($50% of the diameter or $75% of the
cross-sectional area); physician diagnosis of claudication
or ankle-arm systolic blood pressure ratio #0.8; exercise
test positive for claudication; or amputation or other sur-
gery, angioplasty, or thrombolysis for LE PAD.
In the WHI, only the ﬁrst peripheral vascular event,
either AAA or LE PAD, was ascertained. Similarly, if
AAA or LE PAD was diagnosed but not treated during
the reported hospitalization, subsequent treatment or hos-
pitalizations were not captured because the peripheral
vascular end point was already reached. In contrast, CAS
events were considered separately; all events were ascer-
tained up until but not after a WHI-conﬁrmed stroke.
In Medicare data, we used the pilot set to reﬁne and to
test performance of coding algorithms to ascertain carotid
disease, AAA, and LE arterial disease. We used the Interna-
tional Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation (ICD-9-CM) diagnosis and procedure codes
in hospital claims from the MedPAR ﬁles to identify rele-
vant diagnoses and treatment procedures. Up to 10 diag-
nosis codes and six procedure codes may be recorded for
each hospital stay, and all were included in our algorithms
unless otherwise speciﬁed. Both relevant diagnosis and pro-
cedures were required for ascertainment of a treatment
procedure. For each participant, we used the ﬁrst carotid
event or the ﬁrst peripheral vascular event (either AAA or
LE PAD) during the period of overlap with WHI follow-
up. After selecting initial coding algorithms based on cod-
ing descriptions, clinical practice experience, and published
literature,5,9,10 we assessed agreement with WHI data,
analyzed reasons for disagreement, and reﬁned the algo-
rithms as needed with use of the pilot data set. The ﬁnal
set of codes is shown in Table I.
Agreement analysis. We assessed the overlap agree-
ment beyond chance between WHI and Medicare data
Table I. Diagnostic and procedure codes used for Medicare data extraction
Vascular
condition ICD-9-CM diagnosis codes ICD-9-CM procedure codes CPT procedure codes
AAA 441.3, 441.4, 441.5, or
441.9
38.34, 38.44, 39.25, 39.52, or 39.71 35081, 35082, 35102, 35103, 35091, 0001T,
0002T, 34800, 34802, 34803, 34804, 34805,
34830, 34831, or 34832
LE PAD 440.20-440.24, 440.9,
443.9, 444.22, 444.81,
447.1, 443.81, or 250.70
39.50, 39.90, 00.55, 17.56, 99.10,
38.08, 38.14, 38.16, 38.18, 39.25,
39.29, 84.11, 84.12, 84.15, or 84.17
35583, 35556, 35585, 35571, 35587, 35621,
35654, 35646, 35651, 35656, 35661, 35351,
35355, 35371, 35302, 35303, 35305, 34201,
34203, 35666, 35665, 35681, 27590, 27880,
27882, 27884, 28805, 28810, 28820, 28825,
37205, 35474, 35473, 35472, 35471, 37226,
37227, 37228, 37229, 37230, 37231, 35470,
35491, 35492, 35493, 35494, 35495, 35606,
37220, 37221, 37224, or 37225
CAS 433.10, 433.30, 447.1,
or 433.11
38.42, 38.12, 39.90, or 00.63 35301, 35390, 37215, 37216, 0005T, 0075T, or
0076T
AAA, Abdominal aortic aneurysm; CAS, carotid artery stenosis; CPT, Current Procedural Terminology; ICD-9-CM, International Classiﬁcation of Diseases,
Ninth Revision, Clinical Modiﬁcation; LE PAD, lower extremity peripheral artery disease.
Table II. Comparison of number of vascular events with
WHI vs CMS data, pilot data set, 1993-2007
WHI CMS k
Admissions with a treatment procedure
AAA 29 41 0.74
LE PAD 204 255 0.65
CAS 281 317 0.86
Admissions with diagnosis onlya
AAA 7 4 0.18
LE PAD 39 18 0.07
CAS 104 3 0.02
Admissions with diagnosis onlyb
AAA 7 91 0.10
LE PAD 39 78 0.19
CAS 104 32 0.13
AAA, Abdominal aortic aneurysm; CAS, carotid artery stenosis; CMS,
Centers for Medicare and Medicaid Services; LE PAD, lower extremity
peripheral artery disease; WHI, Women’s Health Initiative.
Analysis based on a nationwide data set.
aPrincipal diagnosis in Medicare hospital claim.
bAny diagnosis position in Medicare hospital claim.
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previously published scale ranging from slight agreement (k
0.01-0.20) to very good agreement (k 0.81-0.99).11 We
also evaluated reasons for disagreement. To assess agree-
ment between Medicare data and adjudicated medical re-
cords, we also excluded events that were not informative
(eg, medical record not received) and evaluated agreement
with WHI hospitalizations that were reported and adjudi-
cated. When events were discordant in WHI and Medicare
data, we investigated whether relevant treatment pro-
cedures were recorded with Current Procedural Terminol-
ogy (CPT) codes in the Medicare Carrier ﬁles, which
comprise physician and other noninstitutional claims.
To further evaluate treatment procedures found in
Medicare but not in WHI data, we reviewed medical re-
cords available from the central adjudication process for
AAA and LE PAD. Data abstracted included availability
of speciﬁc documents (eg, discharge summary, operative
procedure report); diagnosis and procedure codes recorded
on the face sheet; and whether there was deﬁnitive, sugges-
tive, or no evidence of the procedure within the available
text documents. If the participant’s record had not been
centrally adjudicated, we reviewed subsequent hospital re-
cords when available from the central adjudication process
and searched for notations regarding a history of an AAA
or LE PAD procedure.
On the basis of our analysis of the reasons for disagree-
ment, we reﬁned our coding algorithms and assessed their
performance in the test data set.
RESULTS
AAAs. Records from 50,511 participants were avail-
able in the pilot data set. WHI clinical data collection iden-
tiﬁed 29 treatment procedures for AAA and seven based on
an admission with a diagnosis of AAA. Medicare hospital
claims documented 118 participants with admissions for
AAA, 41 (35%) with a treatment procedure for AAA and
91 (65%) with a diagnosis of AAA but not a treatmentprocedure. The k values were 0.74 for receiving a treat-
ment procedure for AAA and 0.10 for only diagnosis of
AAA. The k values for diagnosis only remained low if
only primary diagnosis was included from CMS records
(Table II).
Among the 26 participants with a treatment procedure
in both WHI and Medicare data, the event date matched
exactly in 88.5% and was within 30 days for 92.3%
(Table III). Fifteen participants with a procedure for
AAA in Medicare data did not have a procedure in WHI
data (Table IV), two because the hospitalization was not
reported to WHI and four because records were not adju-
dicated. The remaining nine patients had adjudicated re-
cords that did not identify a procedure.
Table IV shows the original analysis (“All” records) and
two modiﬁed analyses in the rows below that aim to exclude
records that were not informative with regard to performance
Table III. Number (%) of participants with an event in
both WHI and Medicare data and interval between the
recorded dates
AAA
procedures
LE PAD
procedures
CAS
procedures
Number of events 26 149 257
Same date 23 (88.5) 111 (74.5) 230 (89.5)
Within 6 1 day 23 (88.5) 118 (79.2) 239 (93.0)
Within 6 3 days 23 (88.5) 120 (80.5) 241 (93.8)
Within 6 7 days 23 (88.5) 122 (81.9) 246 (95.7)
Within 6 30 days 24 (92.3) 127 (85.2) 247 (96.1)
Exactly 6 365 days 0 1 (0.7) 1 (0.4)
Rangea 1177 to 21491986 to 37582211 to 871
AAA, Abdominal aortic aneurysm; CAS, carotid artery stenosis; LE PAD,
lower extremity peripheral artery disease; WHI, Women’s Health Initiative.
Analysis based on a nationwide data set.
aWHI minus Medicare date.
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reported” excluded discordant events (WHI no, CMS yes)
for which no WHI hospitalization was reported within 6
30 days of the Medicare admission. Because of this, there
was no medical record corresponding to the Medicare event
to assess whether the ICD-9-CM coded event met the WHI
case deﬁnition. The rows labeled “WHI hospitalization adju-
dicated” additionally excluded discordant events for which
hospitalizationswere reported but not adjudicated. The other
cell counts are unchanged.
We identiﬁed 12 mismatches for AAA treatment be-
tween WHI and Medicare data for participants with adju-
dicated admissions (Table V). Three admissions were
captured only with WHI data. Of these, one had a Medi-
care diagnosis code for aortic dissection but not for AAA,
one had a diagnosis and repair code for AAA in the physi-
cian claims (Carrier) ﬁle but not in the hospital ﬁle, and one
had no administrative documentation for repair in either
the MedPAR or Carrier ﬁle. Nine participants had Medi-
care admissions with no WHI report of AAA repair, seven
of whom also had CPT codes for diagnosis and repair in the
Carrier ﬁles in addition to the ICD-9 codes present in the
MedPAR ﬁles. Positive predictive value for MedPAR data
capture was 94% for adjudicated hospitalizations if CPT re-
cords were considered corroborative.
LE PAD. WHI documented 243 total LE PAD ad-
missions in the pilot set, of which 204 participants (84%)
had treatment procedures during the hospitalization.
Medicare data review identiﬁed 333 total admissions, of
which 255 involved treatment procedures. The k values
were 0.65 for admissions with treatment procedures and
0.19 for admissions with diagnosis only (Table II).
Among the 149 participants with an LE PAD treatment
procedure in both WHI and Medicare data, the event date
matched exactly in 75% and was within 30 days for 85%
(Table III). The k values improved to 0.77 for hospitali-
zations with treatment procedures (Table IV).
For treatment of LE PAD, 87 mismatches were identi-
ﬁed for participants with adjudicated admissions. Fifty-ﬁvepatients had treatment documented by WHI but not
captured by Medicare codes. Of these, 35 had physician
claims for a treatment procedure (Table V). Of the remain-
ing 20 mismatches, 14 had MedPAR admissions without
PAD diagnosis or procedure codes. Of these, only one
had a Carrier claim for angioplasty with a diagnosis of
atherosclerosis of the arteries (site unspeciﬁed). The
remainder had no Carrier claims for surgical or endovascu-
lar treatment (5 patients) or had Carrier claims for coronary
intervention (5), renal artery stenosis (1), femoral artery
aneurysm (1), or amputation without a diagnosis of PAD
(1). In addition, six patients had MedPAR records with
PAD diagnosis but no procedure codes. All had carrier
claims with LE PAD procedure codes (four, angioplasty;
one, open surgery; one, amputation).
Medicare hospital claims identiﬁed 32 patients who
had treatment procedures for PAD but were not identiﬁed
by the WHI adjudication process. Of these, 23 had CPT
codes for treatment of LE PAD in the physician’s claims
ﬁle, whereas nine had no corresponding CPT codes. Posi-
tive predictive value for MedPAR data capture was 82% for
adjudicated hospitalizations and 95% if CPT records were
considered corroborative.
Carotid artery disease. WHI adjudication identiﬁed
385 admissions with CAS in the pilot set, of which 281
(73%) had a treatment procedure during the admission.
CMS data extraction identiﬁed 349 total admissions, of
which 317 (91%) included treatment procedures. The k
values were 0.86 for admissions with treatment procedures
and 0.13 for admissions with diagnosis only (Table II). For
the 257 participants with a CAS treatment procedure in
both WHI and Medicare data, the event date matched
exactly in 90% and was within 6 30 days for 96%
(Table III). In comparison of adjudicated records, k values
improved to 0.93 for admissions with treatment and 0.86
for all admissions (Table IV).
Carotid treatment mismatches were present for 40 pa-
tients (Table V).WHI identiﬁed 24 patients receiving carotid
revascularization who were not captured by MedPAR data,
with nine procedures (38%) identiﬁed by CPT codes. Sixteen
cases of carotid revascularization were captured by Medicare
data but not reported byWHI.Of these, 75% hadCPT codes
for revascularization (11, carotid endarterectomy; one, ca-
rotid stent). Positive predictive value for MedPAR data cap-
ture was 94% for adjudicated hospitalizations and 99% if
CPT records were considered corroborative.
In a sensitivity analysis, we were able to review centrally
adjudicated charts of 15 participants with a Medicare-
captured treatment procedure (four, AAA; 11, LE PAD)
that was not conﬁrmed in WHI adjudication. On review,
nine participants had deﬁnitive documentation of a treat-
ment procedure (three, AAA; six, LE PAD) that was not
conﬁrmed by adjudicators. If these records were represen-
tative, we estimated the positive predictive value at 91% to
94% for AAA and 92% for LE PAD.
Once adjustments in the CMS coding algorithm were
complete, we analyzed the test set for agreement. As no al-
gorithm using claims data resulted in acceptable agreement
Table IV. Agreement analysis of WHI and CMS data collection for reported and adjudicated events, pilot data set
WHI yes
CMS yes
WHI no
CMS yes
WHI yes
CMS no
WHI no
CMS no
k
AAA treatment procedure
All 26 15 3 48,922 0.74
WHI hospitalization reported 26 13a 3 48,922 0.76
WHI hospitalization adjudicated 26 9b 3 48,922 0.81
LE treatment procedure
All 149 106 55 50,157 0.65
WHI hospitalization reported 149 56c 55 50,157 0.73
WHI hospitalization adjudicated 149 32d 55 50,157 0.77
Carotid treatment procedure
All 257 60 24 48,315 0.86
WHI hospitalization reported 257 23e 24 48,315 0.92
WHI hospitalization adjudicated 257 16f 24 48,315 0.93
AAA, Abdominal aortic aneurysm; CMS, Centers for Medicare and Medicaid Services; LE, lower extremity; WHI, Women’s Health Initiative.
Analysis based on a nationwide data set.
WHI hospitalization reported: Participants with a Medicare event but not a WHI event are included only if a WHI hospitalization was reported within 6
30 days of the Medicare admission date.
WHI hospitalization adjudicated: Participants with a Medicare event but not a WHI event are included only if a WHI hospitalization was reported within 6
30 days of the Medicare admission date and the hospital record was adjudicated.
aExcludes participants without a hospitalization reported in WHI within 6 30 days (n ¼ 2); 0/2 (0%) died within 1 year of the MedPAR admission date.
bExcludes 4 participants for whom no adjudication was planned.
cExcludes participants without a hospitalization reported in WHI within 30 days (n ¼ 50); 12/50 (24%) died within 1 year of the MedPAR admission date.
dExcludes 21 participants for whom no adjudication was planned and 3 participants for whom adjudication was planned but no records received (2, no record
release; 1, no documents).
eExcludes participants without a hospitalization reported in WHI within 30 days (n ¼ 37); 3/37 (8%) died within 1 year of the MedPAR admission date.
fExcludes 5 participants for whom no adjudication was planned and 2 participants for whom adjudication was planned but no records received (1, no record
release; 1, no documents).
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condition without an associated procedure, for the test
set we therefore deﬁned a vascular event in Medicare
data as a therapeutic procedure. Table VI shows the results
of the test set for such procedures. Concordance for the
test data was good and was generally similar to that of
the pilot data. Among participants with an AAA treatment
procedure in WHI data, the percentage ascertained by
Medicare hospital claims was lower in the test set (71%)
than in the pilot set (90%), but the difference was not sta-
tistically signiﬁcant.
In the test set, 53 of the 62 participants with a treat-
ment procedure in Medicare hospital data (six, AAA; 41,
LE PAD; 15, CAS) that was not identiﬁed in WHI adjudi-
cated hospitalizations also had a physician claim with CPT
code indicating a vascular procedure. Positive predictive
value for MedPAR data capture was 84% (AAA), 81%
(LE PAD), and 96% (CAS) for adjudicated hospitalizations
and 97% (AAA), 97% (LE PAD), and 99% (CAS) if CPT
records were considered corroborative.DISCUSSION
Our study shows that Medicare administrative data
appear to be useful for identifying peripheral vascular treat-
ment procedures. This ﬁnding is supported by previous
studies that have demonstrated utility of administrative
data in capturing procedural events.12,13 For vascular con-
ditions severe enough to require a treatment procedure,
administrative procedural codes are sufﬁciently accurate
to capture both surgical and endovascular procedures.Concordance was very good between the two methods
of data collection, and our analysis suggests that each
method provides similar results for a large data sample.
We believe our study highlights the strengths and limita-
tions of both data sources. Each data source identiﬁed
some events that the other did not. Also, each has its short-
comings, and it may be preferable to augment the clinical
details available in WHI data (which are not available in
Medicare data) with events by use of both data sets.
Enhancement of claims data with clinical information has
been shown to improve risk-adjusted outcomes.14 Our
ﬁndings also support the reliability of administrative data-
base studies when major surgical or vascular procedures
can be accurately deﬁned by billing codes, consistent with
these previous studies.
Mismatches in comparing the two methods appeared
to be due to a variety of factors affecting the data collection
for each of the two data sets. Treatments recorded by
Medicare data but not captured by WHI may have been
from errant coding or, conversely, procedures that were
not captured by the WHI adjudication process. The latter
may be due to the WHI study design, which has overlap
of vascular conditions, and requires the participant or proxy
to report a hospitalization to trigger the adjudication pro-
cess. WHI was a complex study with a large number of out-
comes of interest, and AAA, LE PAD, and CAS were not
among the primary WHI outcomes. Patients admitted
with LE PAD or AAA diagnosis but no treatment would
have reached the vascular end point before treatment; sub-
sequent admissions for treatment would not have been
captured by WHI, and so those participants were excluded
Table V. Summary of mismatches of adjudicated WHI records for participants receiving treatment for vascular disease,
pilot data set
Vascular bed Total mismatches
WHI outcome not captured by CMS CMS-captured outcome not reported by WHI
CPT code present CPT code absent CPT code present CPT code absent
AAA 12 1 2 7 2
PAD 87 35 20 23 9
Carotid 40 9 15 12 4
AAA, Abdominal aortic aneurysm; CMS, Centers for Medicare and Medicaid Services; CPT, Current Procedural Terminology; PAD, peripheral artery disease;
WHI, Women’s Health Initiative.
Analysis based on a nationwide data set.
Table VI. Agreement analysis of WHI and CMS data collection, test data set
WHI yes
CMS yes
WHI no
CMS yes
WHI yes
CMS no
WHI no
CMS no k k 95% conﬁdence interval
AAA treatment procedure
All 32 20 13 49,003 0.66 0.55-0.77
WHI hospitalization reported 32 9a 13 49,003 0.74 0.64-0.85
WHI hospitalization adjudicated 32 6b 13 49,003 0.77 0.67-0.87
LE treatment procedure
All 175 139 54 50,253 0.64 0.60-0.69
WHI hospitalization reported 175 67c 54 50,253 0.74 0.70-0.79
WHI hospitalization adjudicated 175 41d 54 50,253 0.79 0.74-0.83
Carotid treatment procedure
All 320 77 27 48,612 0.86 0.83-0.89
WHI hospitalization reported 320 21e 27 48,612 0.93 0.91-0.95
WHI hospitalization adjudicated 320 15f 27 48,612 0.94 0.92-0.96
AAA, Abdominal aortic aneurysm; CMS, Centers for Medicare and Medicaid Services; LE, lower extremity; WHI, Women’s Health Initiative.
Analysis based on a nationwide data set.
WHI hospitalization reported: Participants with a Medicare event but not a WHI event are included only if a WHI hospitalization was reported within 6
30 days of the Medicare admission date.
WHI hospitalization adjudicated: Participants with a Medicare event but not a WHI event are included only if a WHI hospitalization was reported within 6
30 days of the Medicare admission date and the hospital record was adjudicated.
aExcludes participants without a hospitalization reported in WHI within 6 30 days (n ¼ 11); 2 (18%) died within 1 year of the MedPAR admission date.
bExcludes 1 participant for whom no adjudication was planned and 2 participants for whom adjudication was planned but no medical records were received (0,
no record release; 2, no documents).
cExcludes participants without a hospitalization reported in WHI within 6 30 days (n ¼ 72); 14 (19%) died within 1 year of the MedPAR admission date.
dExcludes 25 participants for whom no adjudication was planned and 1 participant for whom adjudication was planned but no records received (1, no record
release).
eExcludes participants without a hospitalization reported in WHI within 6 30 days (n ¼ 56); 8 (14%) died within 1 year of the MedPAR admission date.
fExcludes 6 participants for whom no adjudication was planned and 0 participants for whom adjudication was planned but no records received.
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derwent carotid surgery after a stroke admission would not
have been captured because stroke was the deﬁned end
point for that condition.
Participant failure to report speciﬁc hospitalizations may
have been due to multiple hospitalizations within a single
reporting period, as is often the pattern for PAD. When a
participant died, reasons for hospitalizations shortly before
death may not have been reported completely by proxies.
The methods used for outcome ascertainment in WHI
involved processes that are used in many large clinical trials
and some observational studies to rigorously evaluate out-
comes. However, the processes depend on participant or
proxy report of hospitalization (or speciﬁc outcomes) as a
trigger for medical record review. Reasons for mismatch,
such as lack of reported hospitalization as a key reason thatsome Medicare events were not found in WHI, can inform
other studies that use similar outcome ascertainmentmethods
triggered by participant report. Barriers to accurate adjudica-
tionmay have included incomplete or conﬂicting documenta-
tion in available medical records. Treatment for diagnoses
closely related to the conditions of interest, such as aortic
dissection, peripheral aneurysms, or PAD involving the
visceral or upper extremity arteries, may have been chal-
lenging todistinguish.Our reviewof availablemedical records
with CMS but no WHI capture of AAA and LE PAD proce-
dures identiﬁed that amajority did have deﬁnitive evidence for
such vascular procedures, suggesting that the data collection
and veriﬁcation process likely resulted in underreporting of
hospitalizations with vascular procedures.
Although errors in CMS administrative codes in some
cases may have led to incorrect documentation of events
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for most mismatches. Nearly three fourths of adjudicated
mismatched participants with ICD-9-CM procedural codes
in the hospital claims ﬁles also had matching CPT codes in
the physician claims ﬁles. As these codes are submitted by
separate entities (hospital claims by hospitals and physician
claims by physician practices or medical groups), it is
doubtful that both groups erroneously submitted claims
for these procedures. Previous research has used physician
claims ﬁles to corroborate hospital claims15; mismatches
without physician claims validation may have been under-
captured by WHI or miscoded in CMS data.
We also determined that some treatment procedures
identiﬁed by WHI were not captured by Medicare hospital
claims. Among participants with a vascular procedure in
WHI data, the percentage identiﬁed in Medicare hospital
data was 92% for carotid procedures but only 71% for
AAA and 76% for LE PAD (test data set). The lower per-
centage for AAA may be partially due to small counts and
random variability; the percentage was higher (90%) in the
pilot set. Also, we found that some of the WHI AAA and
LE PAD procedures were recorded in Medicare physician
billing data. These WHI-reported hospitalizations may
have been overnight stays in a 23-hour unit that did not
qualify as an inpatient admission and therefore did not
generate a MedPAR record. This ﬁnding assumes greater
importance as a large proportion of treatments for
vascular disease are performed in the outpatient setting
in many contemporary practices16-18 and emphasizes
the importance of using physician billing data in addition
to hospital claims to augment ascertainment of vascular
treatments for the WHI cohort. Physician claims can be
used in examining treatments that can be performed in
either the inpatient or outpatient setting. Because WHI
does not routinely collect vascular treatments in the
outpatient setting, we were not able to evaluate the over-
all agreement and positive predictive value for this combi-
nation algorithm.
The risk of peripheral vascular events including revas-
cularization procedures and hospitalizations for vascular
conditions has been described in the WHI hormone ther-
apy clinical trials.19,20 These studies may have been limited
by the data collection process and therefore may have
undercaptured vascular procedures, although ascertain-
ment was similar across trial arms. Our analysis suggests
that use of Medicare administrative data can capture
vascular procedures as deﬁned by WHI criteria and vascular
procedures not identiﬁed by WHI criteria to potentially
augment event rates.
Greater disagreement was found between Medicare
and WHI data for AAA, LE PAD, and CAS diagnoses
when a treatment procedure was not required. This was
especially true for AAA and may be partially due to miscod-
ing of diagnoses that were considered (eg, documented as
the reason for a diagnostic test) but not subsequently
conﬁrmed. In addition, true AAA found on an imaging
test might have been included in the hospital diagnosis
codes, but the AAA could have been missed by WHIadjudicators if the imaging test results were not requested
or received. Although imaging tests were routinely
requested when PAD was reported by the participant as
the reason for hospitalization, they may not have been
consistently requested if the record was primarily adjudi-
cated for another condition. Also, an abnormal ﬁnding
on vascular examination of a patient admitted for some
other unrelated primary diagnosis may not have been listed
in the diagnosis codes (limited to 10 codes per admission).
Thus, a limitation for use of Medicare data is its limited
usefulness in capturing WHI-deﬁned diagnosis of vascular
disease that was not associated with a treatment procedure.
Administrative codes for diagnostic procedures cannot
distinguish positive ﬁndings from normal examination ﬁnd-
ings and do not quantify results of diagnostic studies. From
our analysis, it is not possible to determine if hospitalized
patients with a diagnosis code for a vascular condition
had deﬁnitive evidence for that diagnosis or if the code
was inaccurate.
Other limitations include exclusion of women enrolled
in a Medicare HMO. Only women enrolled in fee-for-
service Medicare are currently available in the claims data;
it is unknown if excluding HMO patients from Medicare
analyses introduces bias. It is possible that the health of
Medicare HMO patients is different from that of Medicare
fee-for-service enrollees; however, a recent analysis sug-
gested only minor differences.21
CONCLUSIONS
Medicare data appear useful for identifying vascular
treatment procedures for WHI participants. Medicare hos-
pital claims identify more procedures than WHI does, with
high positive predictive value. Although Medicare hospital
claims do not capture some procedures identiﬁed in WHI,
we found that physician claims augmented ascertainment,
especially for LE PAD procedures. Medicare data may be
useful for ascertaining vascular treatment procedures as
an alternative strategy to traditional ascertainment or as
an additional strategy to augment completeness of
ascertainment.
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